Status:
COMPLETED
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection
Lead Sponsor:
Roei Medical Technologies Ltd.
Conditions:
Bladder Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
RATIONALE: Transurethral resection is a less invasive type of surgery for bladder cancer or benign prostatic hyperplasia. Transurethral resection using a loop resectoscope may have fewer side effects ...
Detailed Description
OBJECTIVES: * Determine the efficacy, in terms of mechanical capabilities, of the Roei loop resectoscope in patients with bladder cancer or benign prostatic hyperplasia undergoing transurethral resec...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of bladder cancer or benign prostatic hyperplasia
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00303654
Start Date
August 1 2005
End Date
June 1 2007
Last Update
March 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, United States, 90095-1781